Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Active Breathing Coordinator-based vs VisionRT-based Deep Inspiration Breath-hold for Radiation for Breast Cancer [NA]
A completed clinical trial comparing Active Breathing Coordinator-based versus VisionRT-based deep inspiration breath-hold strategies for ra…
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Imagio Feasibility Multi-Reader, Multi-Case Study [NA]
A completed feasibility multi-reader, multi-case trial studying Imagio for breast cancer with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment [Phase 3]
Phase 3 trial of trastuzumab emtansine in HER2-positive breast cancer patients who previously received anti-HER2 and chemotherapy; study com…
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Analyzing the Composition of Tears to Identify Cancer [Phase 1, Phase 2]
Phase 1/2 trial exploring tear composition as a biomarker approach for cancer detection, involving breast and ovarian cancer cohorts.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant response-guided treatment for luminal B and luminal A tumors with node metastases in early-sta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC [Phase 3]
Phase 3 trial comparing tesetaxel plus reduced-dose capecitabine versus capecitabine in HER2-negative, HR-positive locally advanced/metastat…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer Patients [Phase 3]
Phase 3 clinical trial evaluating olanzapine for prevention of chemotherapy-induced nausea and vomiting in Chinese breast cancer patients ha…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer [Phase 2]
Phase 2 clinical trial update involving palbociclib in premenopausal women with ER-positive/HER2-negative metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast Cancer [Phase 2]
Phase 2 trial of ADCb (Anlotinib/Docetaxel/Carboplatin) as neoadjuvant therapy for breast cancer is ongoing with status not disclosed.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer [Phase 2]
Phase 2 trial evaluating TAK-228 in combination with tamoxifen for ER-positive, HER2-negative breast cancer has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor [Phase 2]
Phase 2 trial update evaluating safety and efficacy of Q-122 in breast cancer patients on tamoxifen or aromatase inhibitors.
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy [Phase 3]
Phase 3 trial evaluating trastuzumab combined with pertuzumab as adjuvant therapy for breast cancer after neoadjuvant treatment is not yet r…
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer [Phase 3]
Phase 3 trial evaluating palbociclib in combination with an aromatase inhibitor for breast cancer is reported.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy [Phase 4]
Phase 4 trial comparing palbociclib plus letrozole with standard neoadjuvant chemotherapy regimens for breast cancer is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT [Phase 3]
A phase 3 randomized trial evaluating albumin-bound paclitaxel as neoadjuvant therapy for triple-negative breast cancer is underway.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer [Phase 4]
Phase 4 trial comparing albumin-bound paclitaxel plus carboplatin to epirubicin and docetaxel for triple-negative breast cancer is currently…
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer [Phase 2]
Phase 2 trial of a folate receptor alpha peptide vaccine with GM-CSF in patients with breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer [Phase 2]
Phase 2 clinical trial investigating pyrotinib and vinorelbine tartrate capsules with or without inetetamab for first-line treatment in tras…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml® [NA]
A Phase IV trial update for breast brachytherapy using Mammosite-Ml in breast cancer and ductal carcinoma in situ has completed with results…
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer [Phase 2]
Phase 2 trial evaluating everolimus plus cisplatin in triple-negative breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Apatinib in Neoadjuvant Therapy for Patients With Breast Cancer [Phase 2, Phase 3]
Clinical trial update for apatinib in neoadjuvant therapy for breast cancer (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating exemestane with or without entinostat in Chinese patients with hormone receptor-positive, locally advanced or metas…
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating inetetamab with metronomic cyclophosphamide and an aromatase inhibitor in metastatic HER2-positive,…
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating palbociclib in combination with bazedoxifene for hormone receptor–positive breast cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2') [Phase 2]
Phase 2 trial investigating pembrolizumab with paclitaxel for hormone receptor-positive, hypermutated metastatic breast cancer identified by…